ECTRIMS is excited to announce the opening of submissions for the prestigious “Rachel Horne Prize for Women’s Research in MS” for the year 2024.
This year, the annual award of US$40,000 will honour a female scientist whose exceptional clinical research work has improved patient care in women with multiple sclerosis (MS).
The recipient of this award – first established in 2022 during ECTRIMS 2022 – will be selected based on her significant advancements in understanding women’s health challenges and treatment methodologies within the realm of MS. The winner will be revealed during ECTRIMS 2024, to be held 18-20 September in Copenhagen, Denmark.
Nominations for the Rachel Horne Prize can be submitted through the designated online application portal on the Rachel Horne website:
Submit your nomination here >> https://www.rachelhorneprize.com/criteria-nominations
*About the Prize:
The Prize is intended for mid-to-senior career women MS scientists and neurologists. Applicants must have worked for more than 15 years at Assistant Professor level and, at the time of application, hold the title of Associate Professor or Professor. Applicants should identify as female. There are no specific requirements in respect of residency or citizenship.
Applications are to be submitted online by the applicant and should include a CV and a Letter of Reference, describing why the applicant is suitable for the prize. Previous applicants are welcome to re-submit their entry with an updated reference.
Full details of the application process can be found by registering on the online application portal. The deadline for submitting applications is 11 June 2024.
The prize of US$40,000 is to be used at the discretion of the recipient. It is made possible by the generosity of the Horne Family Charitable Foundation and is supported by International Women in MS (iWiMS), ECTRIMS, and the Americas Committee for the Treatment and Research in MS (ACTRIMS).
“iWiMS is delighted to partner with the Rachel Horne Prize for Women’s Research in MS in recognising the important research women neuroscientists conduct that has improved clinical care of women with MS,” says Professor Emmanuelle Waubant, Chair of iWiMS. “For too long, women have been overlooked when it comes to rewarding their research into MS and the particular issues facing women with MS are often given insufficient attention.”
About Rachel Horne:
Rachel Horne, diagnosed with multiple sclerosis in 2009, embarked on a journey to explore the disease from a patient’s perspective, leveraging her background in journalism. She recognized the scarcity of information concerning women’s health issues in MS, despite women comprising two-thirds of MS diagnoses.
Motivated by the lack of recognition for women neurologists and scientists in MS research, Rachel established the Rachel Horne Prize for Women’s Research in MS through the Horne Family Charitable Foundation in Canada, established by her father in 2010, aiming “to do good in the world.”
About the Horne Family Charitable Foundation:
The Horne Family Charitable Foundation, enabled by the generosity of the Horne family, aims to empower the recipient to drive positive change within the MS research community.
The foundation, guided by the philanthropic vision of Stuart Horne, strives to impact education, environmental conservation, humanitarian efforts, and medical research. Administered by the Aqueduct Foundation in Vancouver, Canada, it remains dedicated to shaping a better world.
*Excerpt sourced from Rachel Horne Press Release.